Montereydiscovered thousands of weapons after stopping a dhow in the North Arabian Sea.
The dhow was carrying at least 2,000 assault rifles, machine guns, anti-tank rocket launchers, and anti-tank missiles.
The
Monterey was enforcing a United Nations-led arms embargo on Yemen when it discovered the weapons.
A routine patrol by U.S. naval and Coast Guard forces uncovered a major haul of what the U.S. Navy described as “illicit” weapons last week.
➡
On May 6, Coast Guard personnel operating from the guided missile cruiser USS
Monterey stopped a “stateless” dhow, or local commercial ship that isn’t registered under the flag of any particular country, during an inspection in the North Arabian sea. The dhow was carrying hundreds of assault rifles, sniper rifles, machine guns, anti-tank weapons, and even anti-tank missiles, which were likely bound for Iranian-backed Houthi rebels in Yemen.
China’s Sinopharm COVID-19 vaccine has been approved for emergency use by the World Health Organisation (WHO).
This development was contained in a statement on Friday in which WHO said the decision was part of efforts to improve access to vaccines to curb the spread of the coronavirus.
Sinopharm is the sixth vaccine after Pfizer/BioNTech, Astrazeneca-SK Bio, Serum Institute of India, Janssen and Moderna vaccines, listed for emergency use.
The emergency use listing (EUL), according to the global health body, will also provide more options for countries interested in accessing vaccines via the United Nations-led COVAX facility African countries are procuring vaccines via the COVAX facility.
Advertisement
“In the case of the Sinopharm vaccine, the WHO assessment included on-site inspections of the production facility. The Sinopharm product is an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell). Its easy storage requirements make it highly suitable for low-resource settings. It is the also first vaccine that will carry a vaccine vial monitor, a small sticker on the vaccine vials that change color as the vaccine is exposed to heat, letting health workers know whether the vaccine can be safely used.
“WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has also completed its review of the vaccine. On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks. Vaccine efficacy for symptomatic and hospitalised disease was estimated to be 79%, all age groups combined.
The dire human rights situation in the Philippines under the Duterte administration calls for stronger international solidarity and support and the establishment of a United Nations-led probe on state-perpetrated rights violations, according to a .